617 related articles for article (PubMed ID: 16481279)
41. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
[TBL] [Abstract][Full Text] [Related]
42. [The study on high-resolution HLA and human cytomegalovirus (HCMV) viremia in bone marrow transplantation recipients].
Ma YD; Li MH; Meng XQ; Huang YP; Hu JH; Chin XM; Fan J; Ma WH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Dec; 25(6):427-30. PubMed ID: 22734226
[TBL] [Abstract][Full Text] [Related]
43. Cytomegalovirus infection and development of biliary complications after liver transplantation.
Halme L; Hockerstedt K; Lautenschlager I
Transplantation; 2003 Jun; 75(11):1853-8. PubMed ID: 12811245
[TBL] [Abstract][Full Text] [Related]
44. The risk factors for cytomegalovirus syndrome and tissue-invasive cytomegalovirus disease in liver transplant recipients who have cytomegalovirus antigenemia.
Kim JM; Kim SJ; Joh JW; Shin M; Moon JI; Jung GO; Choi GS; Kwon CH; Lee SK
Transplant Proc; 2010 Apr; 42(3):890-4. PubMed ID: 20430198
[TBL] [Abstract][Full Text] [Related]
45. [Cytomegalovirus antigenemia in the differential diagnosis of pulmonary infiltrates after allogeneic bone marrow transplantation].
Gondo H; Harada M; Minematsu T; Akashi K; Hayashi S; Taniguchi S; Yamasaki K; Shibuya T; Takamatsu Y; Eto T
Rinsho Ketsueki; 1993 Nov; 34(11):1438-44. PubMed ID: 8254905
[TBL] [Abstract][Full Text] [Related]
46. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
[TBL] [Abstract][Full Text] [Related]
47. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
[TBL] [Abstract][Full Text] [Related]
48. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment.
Hazar V; Ugur A; Colak D; Saba R; Tezcan G; Kupesiz A; Karadogan I; Gultekin M; Yesilipek A; Undar L
Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338
[TBL] [Abstract][Full Text] [Related]
49. [Cytomegalovirus infection in patients after kidney transplantation].
Nouza M; Korcáková L
Cas Lek Cesk; 1996 Jul; 135(14):454-7. PubMed ID: 8925546
[TBL] [Abstract][Full Text] [Related]
50. [Detection of cytomegalovirus antigens and virus DNA in the peripheral blood after organ transplantation].
Xiao Y; Shi K; Mao X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Sep; 13(3):287-90. PubMed ID: 12569767
[TBL] [Abstract][Full Text] [Related]
51. Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in adult liver transplant recipients: diagnosis based on antigenemia.
Sampaio AM; Thomasini RL; Guardia AC; Stucchi RS; Rossi CL; Costa SC; Boin IF
Transplant Proc; 2011 May; 43(4):1357-9. PubMed ID: 21620128
[TBL] [Abstract][Full Text] [Related]
52. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients.
Jaskula E; Dlubek D; Duda D; Bogunia-Kubik K; Mlynarczewska A; Lange A
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1296-305. PubMed ID: 19747638
[TBL] [Abstract][Full Text] [Related]
53. [Evaluation of viral load and antigenemia as markers for relapse cytomegalovirus infection in renal transplant recipients].
Franco A; Serrano R; Gimeno A; de Juan J; Merino E; Jiménez del Cerro L; Olivares J
Nefrologia; 2007; 27(2):202-8. PubMed ID: 17564566
[TBL] [Abstract][Full Text] [Related]
54. Usefulness of the cytomegalovirus (CMV) antigenemia assay for predicting the occurrence of CMV disease and death in patients with AIDS.
Chevret S; Scieux C; Garrait V; Dahel L; Morinet F; Modaï J; Decazes JM; Molina JM
Clin Infect Dis; 1999 Apr; 28(4):758-63. PubMed ID: 10825035
[TBL] [Abstract][Full Text] [Related]
55. CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin).
Zintl F; Färber I; Hermann J; Fuchs D; Prager J; Wutzler P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):557-64. PubMed ID: 2480308
[TBL] [Abstract][Full Text] [Related]
56. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
Pajand O; Ziyaeyan M; Mousavi S; Fatolahzadeh B; Hojabri Z; Bahador A; Abdossamadi Z
Exp Clin Transplant; 2008 Jun; 6(2):149-54. PubMed ID: 18816243
[TBL] [Abstract][Full Text] [Related]
57. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection.
van den Berg AP; Klompmaker IJ; Haagsma EB; Peeters PM; Meerman L; Verwer R; The TH; Slooff MJ
Clin Transplant; 1996 Apr; 10(2):224-31. PubMed ID: 8664524
[TBL] [Abstract][Full Text] [Related]
58. Comparison of cytomegalovirus pp-65 antigenemia assay and plasma DNA correlation with the clinical outcome in transplant recipients.
de Oña M; Melón S; Galarraga MC; Palacio A; Lambert JL; Bernardo MJ; Rodríguez M; Gómez E
Transpl Int; 2005 Jan; 18(1):43-6. PubMed ID: 15612982
[TBL] [Abstract][Full Text] [Related]
59. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
Singh N; Wannstedt C; Keyes L; Wagener MM; Cacciarelli TV
Liver Transpl; 2005 Jun; 11(6):700-4. PubMed ID: 15915496
[TBL] [Abstract][Full Text] [Related]
60. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
